TIDMMTPH

Midatech Pharma PLC

09 June 2021

9 June 2021

Midatech Pharma PLC

("Midatech" or the "Company")

Investor Webinar Scheduled for 17 June 2021

Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, will be hosting an investor webinar focused on the Company's various R&D programmes at 2.00pm BST / 9.00am EST on 17 June 2021.

The webinar is open to all existing and potential shareholders and those interested in attending may register via the following link, where following registration they will be provided with access details:

https://us02web.zoom.us/webinar/register/WN_9dDM5-NrRWe6eMAaiGtBLA

Participants may submit questions during the webinar or in advance via email to: midatech@investor-focus.co.uk

For more information, please contact:

 
 Midatech Pharma PLC 
 Stephen Stamp, CEO, CFO 
 Tel: +44 (0)29 20480180 
 www.midatechpharma.com 
 
 Panmure Gordon (UK) Limited (Nominated Adviser and Joint Broker) 
 Freddy Crossley, Emma Earl (Corporate Finance) 
 Rupert Dearden (Corporate Broking) 
 Tel: +44 (0)20 7886 2500 
 
  Turner Pope Investments (TPI) Limited (Joint Broker) 
 Andrew Thacker / James Pope (Corporate Broking) 
 Tel: +44(0)20 3657 0050 
 
 IFC Advisory Limited (Financial PR and UK Investor Relations) 
 Tim Metcalfe / Graham Herring 
 Tel: +44 (0)20 3934 6630 
 Email: midatech@investor-focus.co.uk 
 
 Edison Group (US Investor Relations) 
  Megan Paul 
  Tel: +1 (646) 653 7034 
  Email: mpaul@edisongroup.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADKFBKABKDCAK

(END) Dow Jones Newswires

June 09, 2021 02:00 ET (06:00 GMT)

Midatech Pharma (LSE:MTPH)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024 Click aqui para mais gráficos Midatech Pharma.
Midatech Pharma (LSE:MTPH)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024 Click aqui para mais gráficos Midatech Pharma.